224 related articles for article (PubMed ID: 33586614)
1. The role and mechanism of miR-557 in inhibiting the differentiation and maturation of megakaryocytes in immune thrombocytopenia.
Wang Y; Guo Y; Zhang X; Zhao H; Zhang B; Wu Y; Zhang J
RNA Biol; 2021 Nov; 18(11):1953-1968. PubMed ID: 33586614
[TBL] [Abstract][Full Text] [Related]
2. Effect of thrombopoietin receptor agonists on the apoptotic profile of platelets in patients with chronic immune thrombocytopenia.
Mitchell WB; Pinheiro MP; Boulad N; Kaplan D; Edison MN; Psaila B; Karpoff M; White MJ; Josefsson EC; Kile BT; Bussel JB
Am J Hematol; 2014 Dec; 89(12):E228-34. PubMed ID: 25132654
[TBL] [Abstract][Full Text] [Related]
3. Some viral microRNAs were up-regulated in megakaryocytes incubated with immune thrombocytopenia plasma.
Wang Y; Huang R; Song C; Hu H; Zhang M
Eur J Haematol; 2013 Mar; 90(3):220-7. PubMed ID: 23282244
[TBL] [Abstract][Full Text] [Related]
4. miR-106b-5p induces immune imbalance of Treg/Th17 in immune thrombocytopenic purpura through NR4A3/Foxp3 pathway.
Li JQ; Tian JM; Fan XR; Wang ZY; Ling J; Wu XF; Yang FY; Xia YL
Cell Cycle; 2020 Jun; 19(11):1265-1274. PubMed ID: 32323598
[TBL] [Abstract][Full Text] [Related]
5. Low-dose decitabine promotes megakaryocyte maturation and platelet production in healthy controls and immune thrombocytopenia.
Zhou H; Hou Y; Liu X; Qiu J; Feng Q; Wang Y; Zhang X; Min Y; Shao L; Liu X; Li G; Li L; Yang L; Xu S; Ni H; Peng J; Hou M
Thromb Haemost; 2015 May; 113(5):1021-34. PubMed ID: 25566808
[TBL] [Abstract][Full Text] [Related]
6. Thrombopoietin receptor agonist (TPO-RA) treatment raises platelet counts and reduces anti-platelet antibody levels in mice with immune thrombocytopenia (ITP).
Kapur R; Aslam R; Speck ER; Rebetz JM; Semple JW
Platelets; 2020; 31(3):399-402. PubMed ID: 31146647
[TBL] [Abstract][Full Text] [Related]
7. Immune thrombocytopenia induces autophagy and suppresses apoptosis in megakaryocytes.
Liu Z; Mei T
Mol Med Rep; 2018 Oct; 18(4):4016-4022. PubMed ID: 30106156
[TBL] [Abstract][Full Text] [Related]
8. Circulating microRNAs in patients with immune thrombocytopenia before and after treatment with thrombopoietin-receptor agonists.
Garabet L; Ghanima W; Rangberg A; Teruel-Montoya R; Martinez C; Lozano ML; Nystrand CF; Bussel JB; Sandset PM; Jonassen CM
Platelets; 2020; 31(2):198-205. PubMed ID: 30885035
[TBL] [Abstract][Full Text] [Related]
9. Downregulation of ADAM17 in pediatric immune thrombocytopenia impairs proplatelet formation.
Wang Q; Wei J; Jia X; Feng X; Ji Z; Ji X; Shao X
BMC Pediatr; 2022 Mar; 22(1):164. PubMed ID: 35354403
[TBL] [Abstract][Full Text] [Related]
10. Investigation of megakaryocyte apoptosis in children with acute and chronic idiopathic thrombocytopenic purpura.
Uçar C; Oren H; Irken G; Ateş H; Atabay B; Türker M; Vergin C; Yaprak I
Eur J Haematol; 2003 Jun; 70(6):347-52. PubMed ID: 12756015
[TBL] [Abstract][Full Text] [Related]
11. Aberrant expression of microRNA in CD4
Hua M; Li J; Wang C; Shao L; Hou M; Peng J; Feng Q
Thromb Res; 2019 May; 177():70-78. PubMed ID: 30856381
[TBL] [Abstract][Full Text] [Related]
12. Thrombopoietin, but not cytokines binding to gp130 protein-coupled receptors, activates MAPKp42/44, AKT, and STAT proteins in normal human CD34+ cells, megakaryocytes, and platelets.
Majka M; Ratajczak J; Villaire G; Kubiczek K; Marquez LA; Janowska-Wieczorek A; Ratajczak MZ
Exp Hematol; 2002 Jul; 30(7):751-60. PubMed ID: 12135673
[TBL] [Abstract][Full Text] [Related]
13. Antibody binding to megakaryocytes in vivo in patients with immune thrombocytopenia.
Arnold DM; Nazi I; Toltl LJ; Ross C; Ivetic N; Smith JW; Liu Y; Kelton JG
Eur J Haematol; 2015 Dec; 95(6):532-7. PubMed ID: 25684257
[TBL] [Abstract][Full Text] [Related]
14. Bone marrow examination in patients with immune thrombocytopenia: is there anything different in older patients?
Gunduz E; Kivanc BK; Arik D; Isiksoy S; Bal C; Akay OM
Eur J Haematol; 2014 Aug; 93(2):157-60. PubMed ID: 24660825
[TBL] [Abstract][Full Text] [Related]
15. Biology and chemistry of thrombopoietic agents.
Kuter DJ
Semin Hematol; 2010 Jul; 47(3):243-8. PubMed ID: 20620435
[TBL] [Abstract][Full Text] [Related]
16. Immune Thrombocytopenia Plasma-Derived Exosomes Impaired Megakaryocyte and Platelet Production through an Apoptosis Pathway.
Miao W; Song B; Shi B; Wan Q; Lv Q; Chen H; Zhu M; Zhang L; Han Y; Wu D
Thromb Haemost; 2021 Apr; 121(4):495-505. PubMed ID: 33124021
[TBL] [Abstract][Full Text] [Related]
17. Contributions of TRAIL-mediated megakaryocyte apoptosis to impaired megakaryocyte and platelet production in immune thrombocytopenia.
Yang L; Wang L; Zhao CH; Zhu XJ; Hou Y; Jun P; Hou M
Blood; 2010 Nov; 116(20):4307-16. PubMed ID: 20671119
[TBL] [Abstract][Full Text] [Related]
18. Plasma thrombopoietin levels in thrombocytopenic states: implication for a regulatory role of bone marrow megakaryocytes.
Hou M; Andersson PO; Stockelberg D; Mellqvist UH; Ridell B; Wadenvik H
Br J Haematol; 1998 Jun; 101(3):420-4. PubMed ID: 9633881
[TBL] [Abstract][Full Text] [Related]
19. Serum thrombopoietin (TPO) levels in patients with amegakaryocytic thrombocytopenia are much higher than those with immune thrombocytopenic purpura.
Mukai HY; Kojima H; Todokoro K; Tahara T; Kato T; Hasegawa Y; Kobayashi T; Ninomiya H; Nagasawa T; Abe T
Thromb Haemost; 1996 Nov; 76(5):675-8. PubMed ID: 8950771
[TBL] [Abstract][Full Text] [Related]
20. Regulation of serum thrombopoietin levels by platelets and megakaryocytes in patients with aplastic anaemia and idiopathic thrombocytopenic purpura.
Ichikawa N; Ishida F; Shimodaira S; Tahara T; Kato T; Kitano K
Thromb Haemost; 1996 Aug; 76(2):156-60. PubMed ID: 8865522
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
